Second anniversary of the Global Action to eliminate Cervical Cancer
0
2022-11-18
November 17, 2022 is the second anniversary of the World Health Organization's (WHO) Global Strategy to Accelerate the Elimination of Cervical Cancer, two years after 194 countries, including China, pledged to eliminate cervical cancer.
On this occasion, initiated by WHO, the School of Medicine and Public Health of Peking Union Medical College, the Training Center of Peking Union Medical College, the Cancer Prevention and Control Committee of the Chinese Preventive Medicine Association, the China Health Promotion and Education Association, and the Beijing Wuliande Public Welfare Foundation co-sponsored the "WHO Global Action to Eliminate Cervical Cancer Second Anniversary" commemorative activity and a series of special lectures on cervical cancer prevention and control, aiming to transmit cervical cancer related knowledge through various channels, improve the awareness of cervical cancer prevention and control, and keep women away from cervical cancer. Join hands to create a better future without cervical cancer.
In 2021, YanengBIO fully supported the "First Anniversary of the Global Action to Eliminate Cervical Cancer - Light Up the Landmark" activity, and in 2022, as a supporting unit of Maanshan Station, participating in related activities. As a leading enterprise in cervical cancer screening in China, YanengBIO will continue to contribute to the great cause of cervical cancer elimination in China with our brilliant products and services.
List of YanengBIO’s Cervical Cancer Series
· Human Papillomavirus Genotyping Kit for 14 high-risk types (PCR-Multicolor Melting Curve)
· Human Papillomavirus Nucleic Acid Detection and HPV16/18 Genotyping Kit (PCR-Fluorescence Probing)
· Human Papillomavirus Genotyping Kit for 23 Types (PCR-Reverse Dot Blot)
· DNA Methylation Detection for Human PAX1, SOX1, HAS1 Gene (PCR-Fluorescence Probing)
· Human Papillomavirus Genotyping Kit for 15 Types (PCR - Reverse Dot Blot)
On this occasion, initiated by WHO, the School of Medicine and Public Health of Peking Union Medical College, the Training Center of Peking Union Medical College, the Cancer Prevention and Control Committee of the Chinese Preventive Medicine Association, the China Health Promotion and Education Association, and the Beijing Wuliande Public Welfare Foundation co-sponsored the "WHO Global Action to Eliminate Cervical Cancer Second Anniversary" commemorative activity and a series of special lectures on cervical cancer prevention and control, aiming to transmit cervical cancer related knowledge through various channels, improve the awareness of cervical cancer prevention and control, and keep women away from cervical cancer. Join hands to create a better future without cervical cancer.
In 2021, YanengBIO fully supported the "First Anniversary of the Global Action to Eliminate Cervical Cancer - Light Up the Landmark" activity, and in 2022, as a supporting unit of Maanshan Station, participating in related activities. As a leading enterprise in cervical cancer screening in China, YanengBIO will continue to contribute to the great cause of cervical cancer elimination in China with our brilliant products and services.
List of YanengBIO’s Cervical Cancer Series
· Human Papillomavirus Genotyping Kit for 14 high-risk types (PCR-Multicolor Melting Curve)
· Human Papillomavirus Nucleic Acid Detection and HPV16/18 Genotyping Kit (PCR-Fluorescence Probing)
· Human Papillomavirus Genotyping Kit for 23 Types (PCR-Reverse Dot Blot)
· DNA Methylation Detection for Human PAX1, SOX1, HAS1 Gene (PCR-Fluorescence Probing)
· Human Papillomavirus Genotyping Kit for 15 Types (PCR - Reverse Dot Blot)
